These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 30193081)
81. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. Naruse S; Ishiguro H; Ko SB; Yoshikawa T; Yamamoto T; Yamamoto A; Futakuchi S; Goto H; Saito Y; Takahashi S J Gastroenterol; 2006 Sep; 41(9):901-8. PubMed ID: 17048055 [TBL] [Abstract][Full Text] [Related]
82. Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial. Kim H; Yoon YS; Han Y; Kwon W; Kim SW; Han HS; Yoon DS; Park JS; Park SJ; Han SS; Lee SE; Choi SH; Han IW; Kim E; Jang JY Clin Gastroenterol Hepatol; 2020 Apr; 18(4):926-934.e4. PubMed ID: 31520730 [TBL] [Abstract][Full Text] [Related]
83. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study. Kahl S; Schütte K; Glasbrenner B; Mayerle J; Simon P; Henniges F; Sander-Struckmeier S; Lerch MM; Malfertheiner P JOP; 2014 Mar; 15(2):165-74. PubMed ID: 24618443 [TBL] [Abstract][Full Text] [Related]
84. Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis. Duggan SN Proc Nutr Soc; 2017 Nov; 76(4):484-494. PubMed ID: 28735575 [TBL] [Abstract][Full Text] [Related]
85. Can pancreatic steatorrhea be diagnosed without chemical analysis? Nakamura T; Tando Y; Terada A; Watanabe T; Kaji A; Yamada N; Suda T Int J Pancreatol; 1997 Oct; 22(2):121-5. PubMed ID: 9387033 [TBL] [Abstract][Full Text] [Related]
86. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Nakajima K; Oshida H; Muneyuki T; Kakei M Core Evid; 2012; 7():77-91. PubMed ID: 22936895 [TBL] [Abstract][Full Text] [Related]
87. Effectivity of Pancreatic Enzyme Replacement Therapy in Malnourished Children. Güven B; Demir Mis M; Karaman K; Şahin Yaşar A J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):e114-e118. PubMed ID: 32443036 [TBL] [Abstract][Full Text] [Related]
88. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D; J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494 [TBL] [Abstract][Full Text] [Related]
89. Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). Nakamura T; Takebe K; Imamura K; Tando Y; Yamada N; Arai Y; Terada A; Ishii M; Kikuchi H; Suda T Acta Gastroenterol Belg; 1996; 59(1):10-14. PubMed ID: 8686411 [TBL] [Abstract][Full Text] [Related]
90. Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard? Borowitz D; Aronoff N; Cummings LC; Maqbool A; Mulberg AE Pancreas; 2022 Apr; 51(4):310-318. PubMed ID: 35695742 [TBL] [Abstract][Full Text] [Related]
91. Pancreatic exocrine insufficiency occurs in most patients following pancreaticoduodenectomy. Kumar TK; Tewari M; Shukla SK; Mishra SP Indian J Cancer; 2021; 58(4):511-517. PubMed ID: 34975096 [TBL] [Abstract][Full Text] [Related]
92. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study. Marra-Lopez Valenciano C; Bolado Concejo F; Marín Serrano E; Millastre Bocos J; Martínez-Moneo E; Pérez Rodríguez E; Francisco González M; Del Pozo-García A; Hernández Martín A; Labrador Barba E; Orera Peña ML; de-Madaria E Gastroenterol Hepatol; 2018 Feb; 41(2):77-86. PubMed ID: 28935122 [TBL] [Abstract][Full Text] [Related]
93. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Lindkvist B; Phillips ME; Domínguez-Muñoz JE Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045 [TBL] [Abstract][Full Text] [Related]
94. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971 [TBL] [Abstract][Full Text] [Related]